Can Insulin-Dependent Diabetics Fly to Space?
Astronauts on the International Space Station (ISS) will conduct research to determine if insulin-dependent diabetics can stay in space for short durations. Indian Air Force pilot Shubhanshu Shukla, one of the four astronauts on the Axiom 4 mission, will be part of this experiment. The primary goal is to demonstrate that astronauts with diabetes can be supported in microgravity, which could enable people with diabetes to participate in future space missions.
The project is being carried out in partnership with Burjeel Holdings PLC, a healthcare services provider in the United Arab Emirates. The lead investigators are John Marshall and Alex Rubin, affiliated with Axiom. This research could improve healthcare delivery on Earth, particularly in remote and extreme environments, by enabling remote monitoring and treatment of workers and patients with chronic conditions.
Astronauts on the ISS spend a lot of time conducting experiments and gathering data on how biological processes are affected by microgravity. Studying these processes offers unique opportunities to understand diseases that are difficult to replicate on Earth. The absence of gravity alters cellular behavior, providing deeper insights into conditions like Alzheimer’s, Parkinson’s, and cancer.
Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings, emphasized the significance of this collaboration, stating, "Burjeel Holdings is proud to collaborate on this groundbreaking study aboard Axiom 4, which marks a milestone in medical research and diabetes management. The findings from this study have the potential to benefit future astronauts and translate into meaningful advancements in patient care here on Earth."
